Newsroom

Story title Competitiveness Council - February 2013
Story description

The Competitiveness Council takes place on 18 and 19 February 2013, in Brussels.

Video title EU Patent
Video description

The EU patent that had been discussed for the last 30 years. The main positive aspect of a single EU patent is to reduce costs. This video illustrates the EU Patent regulation with footage of The European Patent Office in Germany,  Sensaris in France and Novozymes in Denmark.

Reference 92958 Video infos Mpg4 / PAL - 16:9 Duration 00:06:55 Type Stockshots (Archives footage)
Shooting date 28-06-2012 Country Germany, France, Denmark Town Munich, Grenoble, Copenhagen    
TC Thumbnail Description
00:00:01

Exterior shots of The European Patent Office (EPO) in Munich (5 shots)

Keywords : European Patents Office Duration : 00:00:26

00:00:27

Interior of view of The European Patent Office (EPO) in Munich (3 shots)

Duration : 00:00:25

00:00:52

European Patent Office expert working on patents (5 shots)

Duration : 00:01:13

00:02:05

Production and testing of sensor devices in an office of Sensaris (23 shots) Sensaris has its headquarters in Grenoble, France. The company provides Sensing Wireless Solutions for environmental, biomedical and leisure matters. Their sensors are made with mobile and web interfaces to manage and broadcast data worldwide. All products are based on the modular platform named Senspod (generic features: Bluetooth communication, GPS, compatible with a wide variety of platforms /Mobile phones, PCs and operating systems /Windows, Mac OS, Linux)

Duration : 00:02:36

00:04:41

Exterior views of Novozymes building, Denmark (3 shots). Novozymes is a biotech-based company, with its headquarters in Denmark, which employs almost 5400 people in 30 countries. Novozymes develops Enzymes for industry, using Microorganisms and Bio pharmaceutical ingredients. The products are used to bleach cotton or in laundry detergents, for example. The company markets approximately 700 products worldwide and has over 6000 patents.

Duration : 00:00:12

00:04:53

Laboratory research and testing at Novozymes (23 shots)

Duration : 00:02:01

00:06:54

End

Duration : 00:00:01